|
Résultats pour
brevets
1.
|
COMPOSITION CONTAINING NATURAL PRODUCT-DERIVED ESSENTIAL OIL EXTRACT AS ACTIVE INGREDIENT FOR IMPROVING RESPIRATORY DISEASES
Numéro d'application |
18565815 |
Statut |
En instance |
Date de dépôt |
2022-04-28 |
Date de la première publication |
2024-08-01 |
Propriétaire |
BOINBIO-CONVERGENCE CO., LTD. (République de Corée)
|
Inventeur(s) |
- Yang, Woong Mo
- Tzeng, Yew-Min
|
Abrégé
The present invention relates to a composition for treating respiratory diseases due to particulate matter, wherein the composition contains, as active ingredients, essential oil extracts of mint, Asarum sieboldi, and fir leaves. A composite obtained by mixing essential oil extracts of mint, Asarum sieboldi, and fir leaves according to the present invention exhibits the effect of relieving the symptoms of chronic respiratory diseases caused by ovalbumin and particulate matter in an animal model, and thus can be effectively used to directly treat respiratory diseases due to particulate matter.
Classes IPC ?
- A61K 36/534 - Mentha (menthe)
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
- A61K 36/15 - Pinaceae (famille du pin), p. ex. pin ou cèdre
- A61K 36/268 - Asarum (cabaret sauvage)
- A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
- A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
|
2.
|
COMPOSITION FOR BODY FAT REDUCTION CONTAINING EXTRACTS OF TARAXACUM PLATYCARPUM AND LONICERAE JAPONICA AS ACTIVE INGREDIENTS
Numéro d'application |
KR2023008023 |
Numéro de publication |
2023/239222 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2023-06-12 |
Date de publication |
2023-12-14 |
Propriétaire |
BOINBIO-CONVERGENCE CO., LTD. (République de Corée)
|
Inventeur(s) |
- Yang, Woong Mo
- Lee, Haesu
|
Abrégé
The present invention relates to a composition for body fat reduction containing extracts of Taraxacum platycarpum and Lonicerae japonica as active ingredients. It has been confirmed that a mixed extract of Taraxacum platycarpum and Lonicerae japonica according to the present invention reduces body weight and body fat when administered to mice with obesity induced by a high-fat diet. Also, it has been confirmed that the mixed extract reduces the size of fat tissue, reduces fat vacuoles in liver tissue, reduces total cholesterol, triglycerides, and LDL-cholesterol in the blood, and increases HDL-cholesterol. Furthermore, it has been confirmed that the mixed extract suppresses the expression of PPAR-γ which is related to fat synthesis. In addition, it has been confirmed that the mixed extract has a synergistic effect on the regulation of intracellular fat accumulation and fat metabolism factors in cells in which fat accumulation is induced.
Classes IPC ?
- A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
- A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée
- A61K 36/355 - Lonicera (chèvrefeuille)
- A61P 3/04 - AnorexigènesMédicaments de l'obésité
- A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
|
3.
|
COMPOSITION FOR LIPOLYSIS COMPRISING EXTRACT OF MORUS ALBA L. BARK AND MAGNOLIA OFFICINALIS BARK AS ACTIVE INGREDIENT
Numéro d'application |
KR2023001872 |
Numéro de publication |
2023/153815 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2023-02-09 |
Date de publication |
2023-08-17 |
Propriétaire |
BOINBIO-CONVERGENCE CO., LTD. (République de Corée)
|
Inventeur(s) |
- Yang, Woong Mo
- Kim, Mi Hye
|
Abrégé
Morus alba LMagnolia officinalis Magnolia officinalis bark, according to the present invention, was topically administered to an animal model with fat accumulation induced by a high-fat diet, the size and weight of adipose tissue in the local area to which the extract was administered were decreased. It was also confirmed that the size of adipocytes in the adipose tissue was reduced, from which it was confirmed that the extract can be used as a composition for local lipolysis.
Classes IPC ?
- A61K 36/60 - Moraceae (famille de la mûre), p. ex. arbre à pain ou figuier
- A61K 36/54 - Lauraceae (famille du laurier), p. ex. cannelle ou sassafras
- A61P 3/04 - AnorexigènesMédicaments de l'obésité
- A61K 8/9789 - Magnoliopsida [dicotylédones]
- A61Q 19/06 - Préparations pour lutter contre la cellulite
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
|
4.
|
COMPOSITION CONTAINING NATURAL PRODUCT-DERIVED ESSENTIAL OIL EXTRACT AS ACTIVE INGREDIENT FOR IMPROVING RESPIRATORY DISEASES
Numéro d'application |
KR2022006126 |
Numéro de publication |
2022/255648 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2022-04-28 |
Date de publication |
2022-12-08 |
Propriétaire |
BOINBIO-CONVERGENCE CO., LTD. (République de Corée)
|
Inventeur(s) |
- Yang, Woong Mo
- Kim, Mi Hye
|
Abrégé
The present invention relates to a composition for preventing, relieving, or treating respiratory diseases due to particulate matter, wherein the composition contains, as active ingredients, essential oil extracts of mint, Asarum sieboldi, and fir leaves. A composite obtained by mixing essential oil extracts of mint, Asarum sieboldi, and fir leaves according to the present invention exhibits the effect of relieving the symptoms of chronic respiratory diseases caused by ovalbumin and particulate matter in an animal model, and thus can be effectively used to directly prevent, relieve, and treat respiratory diseases due to particulate matter.
Classes IPC ?
- A61K 36/534 - Mentha (menthe)
- A61K 36/268 - Asarum (cabaret sauvage)
- A61K 36/15 - Pinaceae (famille du pin), p. ex. pin ou cèdre
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
- A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
- A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
|
5.
|
COMPOSITION FOR DISSOLVING LOCAL FAT, COMPRISING CRUDE DRUG EXTRACT AS ACTIVE INGREDIENT
Numéro d'application |
KR2019009930 |
Numéro de publication |
2020/166773 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2019-08-08 |
Date de publication |
2020-08-20 |
Propriétaire |
BOINBIO-CONVERGENCE CO., LTD. (République de Corée)
|
Inventeur(s) |
- Yang, Woong-Mo
- Kim, Mi-Hye
|
Abrégé
The present invention relates to a composition for dissolving fat, comprising, as an active ingredient, a complex extract of Astragalus membranaceus Bunge, Taraxacum platycarpum H. Dahlstedt, and Pinellia ternata Breitenbach, and can be used usefully for removing fat in a localized area, as the complex extract, if administered to the localized area in the form of an injection, can reduce expression of a fat-generating factor, increase expression of a fat-dissolving factor, and reduce expression of a glyconeogenesis factor in a local fat tissue and, thereby, has the effects of reducing the size of a fat cell in the local fat tissue and reducing the amount of local fat.
|
|